DEFA14A: BlackRock Capital Allocation Term Trust Faces Proxy Battle Ahead of Annual Meeting

BlackRock Capital Allocation Term Trust urges shareholders to vote in favor of its board nominees and against Saba Capital's proposal to terminate BlackRock as investment manager at the upcoming annual meeting.

Summary

• BlackRock Capital Allocation Term Trust (BCAT) is holding its annual meeting on June 26th.
• Shareholders are being asked to vote on board nominees and a proposal by Saba Capital to terminate BlackRock as the investment manager.
• BlackRock highlights its performance, including a 174% increase in distributions since inception, an 11.1% improvement in the discount, generating $198 million in value, and a discount management program offering 9.8% annual liquidity at NAV.
• BlackRock argues that Saba's aim is a quick profit at the expense of the fund and shareholders.
• They also claim Saba's nominees are underqualified and beholden to Saba's interests.
• Independent proxy advisors ISS and Glass Lewis recommend voting against terminating BlackRock and for all Board nominees.
• Shareholders are urged to vote using the WHITE proxy card and disregard any gold proxy cards from Saba.
• The deadline for online voting is 11:59 PM ET on June 25, 2024.

Sentiment

Score: 7

Explanation: The document presents a positive view of BlackRock's performance and a negative view of Saba's intentions, but the proxy battle introduces uncertainty. The support from ISS and Glass Lewis is a positive sign.

Positives

• Distributions have increased by 174% since the fund's inception.
• The discount has improved by 11.1%, generating $198 million in value for shareholders.
• The discount management program provides 9.8% of annual liquidity at NAV.
• Independent proxy advisors ISS and Glass Lewis support BlackRock's position.

Negatives

• Saba Capital is attempting to terminate BlackRock as the investment manager.
• BlackRock claims Saba's nominees are underqualified and self-interested.
• Saba's strategies may involve increased fees and expenses.

Risks

• The proxy battle with Saba Capital creates uncertainty for the fund.
• Saba's proposed changes could lead to riskier strategies.
• Market conditions can impact the fund's dividend yield, market price, and NAV.

Future Outlook

The fund intends to offer to repurchase 2.5% of its outstanding common shares at a price equal to 98% of NAV following the end of applicable quarters if the fund's common shares trade at a discount of more than 7.5% during each of the quarters ended 6/30/24, 9/30/24, 12/31/24 and 3/31/25.

Management Comments

• BlackRock and your Board continue to deliver for you.
• Saba's true aim is a quick profit for themselves at the expense of your Fund and shareholders like you.
• Saba has never launched a closed-end fundjust taken them over.

Industry Context

This proxy battle reflects a broader trend of activist investors targeting closed-end funds to unlock value or influence management decisions.

Comparison to Industry Standards

• It's difficult to directly compare BCAT's performance to specific industry standards without knowing its exact investment strategy and benchmark.
• However, the reported increase in distributions and discount improvement are positive indicators compared to other closed-end funds facing similar market conditions.
• Activist investors like Saba Capital often target funds with persistent discounts to NAV, similar to the situation with BCAT.

Stakeholder Impact

• Shareholders are directly impacted by the outcome of the proxy vote.
• The investment strategy and management of the fund will be affected by the results.
• Employees of BlackRock could be impacted if Saba's proposal is successful.

Next Steps

• Shareholders need to vote before the annual meeting on June 26.
• The fund will monitor its discount to NAV and may offer to repurchase shares if certain conditions are met.

Key Dates

Keywords

BlackRock Capital Allocation Term Trust, BCAT, Saba Capital, Proxy Battle, Annual Meeting, Investment Manager, Distributions, Discount, Shareholders, Board Nominees